KLK3 and prostate adenocarcinoma: The patient selected for this case study was a 78-year-old male patient who presented with adenocarcinoma of the prostate with staging T2c N0 M0, a Gleason score of 4+3, pre-treatment prostate-specific antigen (PSA) of <6, and overall stage IIc.